PMGC Holdings ELAB
NASDAQ ELAB
$1.64 -0.05 (-2.96%)
As of: Nov 11, 2026 · 1:36 PM EST

PMGC Holdings (ELAB) Liabilities from Discontinued Operations (2023 - 2024)

Updated

PMGC Holdings (ELAB) recorded Liabilities from Discontinued Operations of $65,489 in Q4 2023.

Analysis

PMGC Holdings (ELAB) Liabilities from Discontinued Operations (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 PMGC Holdings 824,128.53 -47.54 Mn 385,691.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 548,916.00
Dec 31, 2023 65,489.00
API Access

PMGC Holdings Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=ELAB&period=max&api_key=YOUR_API_KEY